Subcutaneous vs intravenous bortezomib in previously untreated patients with multiple myeloma
Latest Information Update: 26 Sep 2014
At a glance
- Drugs Bortezomib (Primary) ; Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 26 Sep 2014 New trial record